• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Biotech

Realistic white price tags collection Special offer or shopping discount label
Biotech

China biotechs ‘reshaping’ US biopharma: Jefferies report

In 2025's Q1, 32% of outlicensing biotech deal value occurred in China versus 21% reported in both 2024 and 2023, according to Jefferies.
Gabrielle Masson Jul 14, 2025 2:30pm
Whale swimming in ocean seen from above

Merck wades deeper into HIV PrEP waters with pair of trials

Jul 14, 2025 1:12pm
How do you get pharmaceutical treatments where theyre needed most
Sponsored

How to get pharmaceutical treatments where they’re needed most.

Jul 14, 2025 8:00am
MA strategy deal block push come together form

Research non-profit acquires embattled Essa in Xoma-backed deal

Jul 14, 2025 9:30am
Carl Sailer on AI market trends and strategic planning in biotech
Sponsored

Carl Sailer on AI, market trends, and strategic planning in biotech

Oct 28, 2024 8:00pm
Arrows hitting targets

Takeda narcolepsy blockbuster hopeful secures double ph. 3 wins

Jul 14, 2025 5:51am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings